A vaccine against Ebola virus could be ready by 2015, if the most optimistic time of the World Health Organization (WHO) and the pharmaceutical companies are met, said today the director of vaccines that agency, Jean-Marie Okwo Bele.
"Processes can be applied to emergency throughout 2015 a vaccine is available that can be used," said Okwo Bele.
Okwo Bele said the British pharmaceutical Glasxo Smith Klein is the laboratory has more advanced development of the vaccine, which has been tested in animals and found excellent results.
"We in September to start clinical trials, first in the United States and an African country, where the cases are.'ll Have to determine that vaccines do not pose harmful effects, immune response is excellent and determine dose, "the official said.
If the findings are positive, the vaccine can reach the market next year.
The WHO expert said the British pharmaceutical Glasxo Smith Klein is only one candidate for drug development and there are at least four or five others, who are not yet at the stage of beginning clinical trials.
Bele also referred to ZMapp serum applied experimentally infected the two Americans from Liberia.
"Was used rashly, but seems to give excellent results," said the manager of WHO, who lamented not yet have enough of the product for use in the field, where the epidemic is.
For now there is no specific treatment for the Ebola virus attack, which is transmitted by direct contact with blood and body fluids of infected persons or animals, causing severe bleeding and can have a mortality rate of 90 percent.
This is the first time identified and Ebola epidemic in West Africa is confirmed, because until now always had occurred in Central Africa, an outbreak that has so far caused 961 deaths, according to WHO data.
0 comments:
Post a Comment